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Transcription and mRNA processing are regulated by phosphory-
lation and dephosphorylation of the C-terminal domain (CTD) of
RNA polymerase II, which consists of tandem repeats of a
Y1S2P3T4S5P6S7 heptapeptide. Previous studies showed that mem-
bers of the plant CTD phosphatase-like (CPL) protein family differ-
entially regulate osmotic stress-responsive and abscisic acid-
responsive transcription in Arabidopsis thaliana. Here we report
that AtCPL1 and AtCPL2 specifically dephosphorylate Ser-5 of the
CTD heptad in Arabidopsis RNA polymerase II, but not Ser-2. An
N-terminal catalytic domain of CPL1, which suffices for CTD Ser-5
phosphatase activity in vitro, includes a signature DXDXT acylphos-
phatase motif, but lacks a breast cancer 1 CTD, which is an essential
component of the fungal and metazoan Fcp1 CTD phosphatase
enzymes. The CTD of CPL1, which contains two putative double-
stranded RNA binding motifs, is essential for the in vivo function
of CPL1 and includes a C-terminal 23-aa signal responsible for its
nuclear targeting. CPL2 has a similar domain structure but contains
only one double-stranded RNA binding motif. Combining mutant
alleles of CPL1 and CPL2 causes synthetic lethality of the male but
not the female gametes. These results indicate that CPL1 and CPL2
exemplify a unique family of CTD Ser-5-specific phosphatases with
an essential role in plant growth and development.
Transcriptional induction of genes that encode stress tolerancedeterminants is an integral part of the survival strategy of
plants in adverse environments. The Arabidopsis thaliana re-
sponsive to dehydration (RD) genes are prototypal outputs of
stress signal integration activated by low temperature, hyperos-
molarity, and the plant hormone abscisic acid (ABA). The
stress-inducible promoter of the RD29a gene contains dehydra-
tioncold-responsive elements and ABA-responsive elements
that are the targets of distinct families of DNA binding tran-
scription factors (1, 2). The plant stress response is also regulated
by proteins that impact the core RNA polymerase II (Pol II)
transcriptional machinery, the mRNA maturation process, and
chromatin structure (3–9). Analysis of Arabidopsis mutants that
display hyperinduction of RD29a expression under stress con-
ditions have identified a family of C-terminal domain (CTD)
phosphatase-like (CPL) genes that negatively regulate stress-
responsive transcription (5, 6). The CPL1 and CPL3 genes
discovered in the screen for hyperinduction are so named
because they encode large polypeptides (967 and 1,241 aa,
respectively) with local primary structure similarity to the Fcp1
family of fungal and metazoan protein serine phosphatases,
which regulate transcription by dephosphorylating the CTD of
the largest subunit of RNA Pol II (10).
The Pol II CTD is composed of a tandemly repeated
heptapeptide of consensus sequence Y1S2P3T4S5P6S7. The
number of CTD heptad repeats varies widely among species
and correlates roughly with evolutionary complexity; e.g.,
mammals have 52 repeats, Drosophila has 42 repeats, fission
yeast Schizosaccharomyces pombe has 29 repeats, and the
microsporidian Encephalitozoon cuniculi has 15 repeats. The
CTD of Arabidopsis Pol II consists of 34 heptad repeats.
Studies of CTD function in fungi and metazoans have illumi-
nated its role as a structurally plastic ‘‘landing pad’’ for
proteins that regulate transcription and cotranscriptional
mRNA processing (11). The CTD undergoes waves of phos-
phorylation and dephosphorylation at positions Ser-5 and
Ser-2 during the transcription cycle and in response to envi-
ronmental stress (10). Remodeling of the CTD phosphoryla-
tion array accompanies the transition from initiation to elon-
gation modes and controls the recruitment, activity, and egress
of the various mRNA processing machines that act on the
nascent transcript (12–15). Fungi and metazoans encode mul-
tiple protein serine kinases (16) and protein serine phospha-
tases that modify the CTD. Among the CTD phosphatases,
Fcp1 has been studied most intensively (17–20). Fcp1 or-
thologs are large polypeptides (723 aa in S. pombe and 961 aa
in humans) consisting of a conserved central catalytic domain
f lanked by variable N- and C-terminal segments that are
dispensable for CTD phosphatase activity in vitro, but are
collectively required for Fcp1 function in vivo. The minimal
phosphatase domain of S. pombe Fcp1 is a 425-aa polypeptide
composed of two modules: an N-terminal FCP1 homology
(FCPH) domain and a C-terminal breast cancer 1 C terminus
(BRCT) domain, both of which are essential for Fcp1 phos-
phatase activity (21, 22). The FCPH domain of Fcp1 belongs
to the DXDXT family of metal-dependent phosphotrans-
ferases that act via an acyl-phosphoenzyme intermediate (23).
Fcp1 is essential for cell viability in budding and fission yeast
(17, 24), and a partial deficiency of human Fcp1 is associated
with an autosomal recessive developmental disorder (25). A
separate class of human small CTD phosphatases (SCPs),
containing the FCPH domain but not the BRCT domain, has
been described (26). The effects of overexpressing WT and
dominant-negative forms of SCP in mammalian cells suggest
that SCP is a negative regulator of transcription (26).
Virtually nothing is known about the role of the CTD and the
impact of CTD phosphorylation dynamics on gene expression in
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plants. The Arabidopisis CPL proteins, which function genetically
as brakes on stress-induced transcription, provide a starting
point to fill this void. The predicted Arabidopsis proteome
includes four FCPH domain-containing CPL proteins, which can
be grouped into two paralogous pairs. CPL3 and CPL4 contain
a C-terminal BRCT domain, whereas CPL1 and CPL2 do not
(5). Here we address the following questions concerning the
functionality of Arabidopsis CPL1 and CPL2. Do CPL1 and
CPL2 have the CTD phosphatase activities imputed to them on
the basis of local amino acid sequence similarity to Fcp1? If so,
do they display any intrinsic preference for dephosphorylation of
Ser-2 versus Ser-5? Are the structural features that distinguish
CPL1 and CPL2 from CPL3 and CPL4 relevant for activity?
What roles might CPL1 and CPL2 play in plant development,
either individually or in concert?
Materials and Methods
Detailed information is provided in Supporting Text, which is
published as supporting information on the PNAS web site.
Sequences of oligo-DNA primers are shown in Table 2, which is
published as supporting information on the PNAS web site.
CTD Phosphatase Assay. Preparation of synthetic phosphorylated
CTD tetraheptad substrates and dephosphorylation assays were
performed as described (21). GST-AtCTD was prepared as
described (27), phosphorylated by activated ERK2 (Calbio-
chem) (28), and dialyzed overnight against storage buffer (10
mM Hepes, pH 7.910% glycerol0.1% Triton X-100). Phos-
phatase reaction mixtures (10 l) containing 50 mM Tris-acetate
buffer as specified, 2.0 g of phosphorylated GST-AtCTD, 10
mM MgCl2 where specified, and CPLs as specified were incu-
bated for 3 h at 37°C. Ser-2 and Ser-5 phosphorylation status was
analyzed by immunoblotting with H5 and H14 mAbs (Covance),
respectively, and chemiluminescence (Pierce).
Transient Expression of GFP-Fusion Proteins. GFP-CPL1 plasmids
(30 g) were introduced into Arabidopsis protoplasts by poly-
ethylene glycol-mediated transformation as described (29).
Transformed protoplasts were incubated at 22°C in the dark.
Expression of the fusion protein was evaluated 2 and 3 days after
transformation, and images were obtained on an Olympus
AX-70 epifluorescence microscope equipped with standard
FITC and rhodamine filters. Images from a Peltier-cooled 1.3
M-pixel Sensys camera (Roper Scientific, Trenton, NJ) were
captured with the MACPROBE version 4.2.3 digital image system
(Applied Imaging, San Jose, CA) and were then processed by
using PHOTOSHOP software (Adobe Systems, San Jose, CA).
Genetic Analysis. Diheterozygous fry2–1 cpl2–2 plants were
prepared by pollinating fry2–1 plants with cpl2–2 plant pollens
and subsequent PCR screening of F1 plants for T-DNA insertion
in CPL2 locus as described in Supporting Text. The diheterozy-
gous plants were self-pollinated to obtain F2 progeny. The
genotypes of the CPL1 and CPL2 loci of viable F2 seedlings were
determined as described in Supporting Text. For reciprocal cross
analysis, a fry2–1 cpl2–2 plant and a fry2–1 plant were used
as parents. F1 seedlings with homozygous fry2–1 genotype were
selected by using RD29a-LUC expression after cold and ABA
treatments as described (5, 6). The fry2–1 phenotype of the F1
plants indicated that the gametes from the diheterozygous
parent contained the fry2–1 chromosome. Subsequently,
genomic DNA was extracted from each fry2–1 F1 plant and
scored by PCR for the cpl2–2 T-DNA insertion.
Results
CPL12-Like Proteins Are Specific to Plants. CPL1 (967 aa) and
CPL2 (771 aa) are CPLs initially identified in Arabidopsis. They
contain at their N termini an FCPH domain, characteristic of
fungal and metazoan CTD phosphatases, but they lack the
BRCT domain located downstream of the FCPH domains in the
fungal, microsporidian, and metazoan Fcp1 enzymes. Instead,
the CPL1 and CPL2 proteins contain putative double-stranded
RNA binding motifs (dsRBMs) downstream of their FCPH
domains. CPL1 has two dsRBMs, whereas CPL2 has one
dsRBM. The other two Arabidopsis CPLs (CPL3 and CPL4)
resemble the fungal and metazoan Fcp1 phosphatases in that
they have a BRCT domain near their C termini. Deletion
analyses have shown that the BRCT domain is essential for the
phosphatase activity of yeast and metazoan Fcp1 proteins. The
distinctive domain architecture of Arabidopsis CPL1 and CPL2
raises questions about their evolutionary origins and whether
they are bona fide CTD phosphatases.
With respect to the first question, we were able to discern
convincing homologs of CPL1 in the rice proteome (GenBank
accession nos. CAD41201 and BAB63701) and among ESTs
from plants including Nicotiana benthamiana and Medicago
truncatura (GenBank accession nos. CK288050 and BI26702).
An alignment of the full-length sequences of Arabidopsis CPL1
and CPL2 with rice CPL1 and CPL2 is shown in Fig. 5, which is
published as supporting information on the PNAS web site. All
four plant polypeptides contain an N-terminal FCPH domain
that includes the acylphosphatase signature motif DXDXT (res-
idues 161–165 in CPL1). Both of the aspartates of the DXDXT
motif are essential for the activity of fungal, microsporidian, and
metazoan CTD phosphatases (21, 23, 30). The overall identity
between AtCPL1 and OsCPL1 is 45%, whereas AtCPL2 and
OsCPL2 have 38% identity. The FCPH domain is especially well
conserved (50% identity among the four plant CPL1 and CPL2
proteins). In contrast, FCPH domains of AtCPL1 and AtCPL3
are only 18% identical, whereas AtCPL1 and human SCP1 are
26% identical in the FCPH domains. These comparisons indicate
that CPL1 and CPL2 are a distinct lineage of plant-specific CTD
phosphatase-like proteins with unique domain architecture.
Arabidopsis CPL1 and CPL2 Specifically Dephosphorylated Ser-5 of
CTD Heptad Motif. To determine whether CPL1 or CPL2 have
CTD phosphatase activity, we produced them in bacteria as
6His-tagged NusA fusions and isolated the recombinant fusion
proteins from soluble bacterial lysates by Ni-affinity chromatog-
raphy. (We found previously that 6His-CPL1 was completely
insoluble when produced in Escherichia coli; thus, we resorted
here to the 6His-NusA fusion strategy.) SDSPAGE analysis
showed that the affinity-purified material consisted of a heter-
ogeneous array of polypeptides, the largest of which were
consistent with the sizes expected of 6His-NusA-CPL1 and
6His-NusA-CPL2, respectively (Fig. 1A, denoted by arrows),
the most abundant of which was similar in size to 6His-NusA.
Neither the putative full-sized 6His-NusA-CPL proteins nor
the collection of 60- to 130-kDa polypeptides migrating be-
tween them and 6His-NusA were present in the preparation of
recombinant 6His-NusA that was purified in parallel (Fig. 1 A).
We surmise that the CPL1 and CPL2 fusion proteins were
susceptible to proteolysis in E. coli, such that only a minor
fraction of the 6His-NusA fusions recovered contained intact
CPL1 or CPL2. Nonetheless, we assayed the preparations for
CTD phosphatase activity, using purified 6His-NusA and
purified recombinant S. pombe CTD phosphatase Fcp1 as
negative and positive controls, respectively.
To gauge whether the CPLs have CTD phosphatase activity,
and whether they display any preference for the position of
phosphoserine within the CTD heptad, we used synthetic 28-aa
peptides consisting of four tandem heptad repeats phosphory-
lated exclusively at Ser-2 or Ser-5 of each heptad. Reaction of the
CPL1 and CPL2 preparations with the Ser-5-PO4 peptide re-
sulted in Pi release proportional to input protein, whereas the
6His-NusA protein was inactive (Fig. 1B). Addition of 5 g of
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the CPL1 and CPL2 preparations sufficed to hydrolyze 70% and
82% of the input Ser-5-PO4 residues, respectively. The instruc-
tive finding was that the CPL1 and CPL2 preparations did not
catalyze Pi release from the Ser-2-PO4 peptide (Fig. 1C). Note
that the Ser-2-PO4 peptide was an effective substrate for S.
pombe Fcp1 (Fig. 1C).
Dephosphorylation of the Ser-5-PO4 CTD peptide by CPL1
and CPL2 required a divalent cation (Fig. 6 A and B, which is
published as supporting information on the PNAS web site). (All
known DXDXT phosphotransferases are metal-dependent en-
zymes.) Magnesium supported optimal activity at 10 mM con-
centration. Manganese and cobalt (10 mM) were also capable of
satisfying the divalent cation requirement, whereas calcium, zinc,
and copper (10 mM) were ineffective (Fig. 6 A and B). CPL1 and
CPL2 displayed a bell-shaped pH profile with an optimum pH at
5.5–6.0 (Fig. 6C). It is sensible that CPL1 and CPL2, as DXDXT
acyl-phosphatases, would have optimal activity at mildly acidic
pH, because the phosphoryl transfer mechanism calls for an
unprotonated aspartate nucleophile and a protonated aspartate
general acid catalyst. These properties, plus the strong selectivity
of the CPL1 and CPL2 preparations for hydrolysis of Ser-5 versus
Ser-2, suggest that the observed CTD phosphatase activity is
attributable to the recombinant 6His-NusA-CPL1 and 6His-
NusA-CPL2 proteins, their impurity notwithstanding. This at-
tribution is reinforced by ensuing studies of deleted versions of
the CPL1 protein.
The C-Terminal Region of CPL1 Is Dispensable for CTD Ser-5 Phospha-
tase Activity. The primary structures of CPL1 and CPL2 diverge
in their C-terminal regions except for the conserved dsRBMs
(Fig. 5). The fry2–1 mutant allele of CPL1 results in hyperactive
stress-induced transcription and mimics in most respect the
effects of a nonsense mutation in the region of CPL1 encoding
the FCPH domain. The fry2–1 phenotype is attributed to a point
mutation at a splice junction between the eighth exon and the
eighth intron (6). Here, we amplified by RT-PCR a CPL1 cDNA
from mRNA obtained from the fry2–1 mutant, using primers in
the eighth and 10th exons (Fig. 7, which is published as sup-
porting information on the PNAS web site). The cDNA included
the eighth but not the ninth intron, indicating a specific splicing
defect. The eighth intron of CPL1 is 101 nt and contains an
in-frame stop codon. The predicted CPL1 protein encoded by
the fry2–1 mRNA consists of an N-terminal 676-aa fragment of
the WT protein plus a C-terminal tail containing eight extra
amino acids encoded by the included intron. The truncated
mutant protein lacks the C-terminal 292-aa segment of WT
CPL1 that contains the two putative dsRBMs.
To determine whether this deleted region is important for the
catalytic activity of CPL1, we expressed a series of truncated
CPL1 variants as GST fusion proteins in E. coli and isolated them
from soluble extracts by glutathione-agarose affinity chroma-
tography. SDSPAGE analysis of the GST-CPL11–638, GST-
CPL11–563, GST-CPL11–500, and GST-CPL147–638 preparations
revealed polypeptide constituents of the size expected for each
fusion protein (denoted by arrows in Fig. 2A). The preparations
also contained a prominent polypeptide of 60 kDa, which
could correspond to the bacterial chaperone GroEL. It is evi-
dent that the GST fusions of the truncated CPL1 proteins are
purer than the preparations of NusA-CPL1 and NusA-CPL2
analyzed initially. The instructive findings were that 0.1 g of the
CPL11–638 and CPL11–563 proteins catalyzed near quantitative
hydrolysis of the input Ser-5-PO4 substrate, but were virtually
inert with the Ser-2-PO4 substrate (Fig. 2B). We estimated a
minimal turnover number of 0.8 s1 for the Ser-5 phosphatase
activity of the truncated CPL1 proteins, which was comparable
to the observed turnover number (0.4 s1) for hydrolysis of a
Ser-2-PO4 tetraheptad CTD substrate by S. pombe Fcp1 (29).
Although we cannot compare the activity of these truncated
versions with that of full-length CPL1 (because of difficulty
purifying the latter), this experiment demonstrates that deletion
of as many as 404 aa from the C terminus of CPL1 did not ablate
its activity or alter its stringent specificity for dephosphorylation
of Ser-5. We infer that the effects of the C-terminal truncation
of CPL1 in the fry2–1 mutant are likely attributable to defects
other than simple loss of catalytic activity. A further incremental
C-terminal truncation, GST-CPL11–500, resulted in a partial loss
of CTD phosphatase activity, whereas the N-terminal deletion
mutant GST-CPL147–638 was catalytically inactive (Fig. 2B).
CPL1 and CPL2 Dephosphorylate Ser-5 of the Intact Arabidopsis RNA
Pol II CTD. We tested the ability of CPL1 to dephosphorylate the
full-length CTD of Arabidopsis Pol II, which consists of 34
heptads (Fig. 3). Phosphorylation of recombinant GST-AtCTD
by the ERK2 kinase caused a shift in the electrophoretic mobility
of the AtCTD analogous to that seen with metazoan and fungal
Pol IIO and GST-CTDO from human. Accordingly, we desig-
nated this phosphorylated low-mobility form as GST-AtCTDO
and the nonphosphorylated form as GST-AtCTDA. GST-
AtCTDO was recognized by mAbs specific to Ser-5-PO4 (H14)
and Ser-2-PO4 (H5), consistent with previous studies (26, 28).
Fig. 1. CTD phosphatase activity of AtCPL proteins. (A) Protein preparations. Aliquots of the nickel-agarose preparations of S. pombe Fcp1 (SpFcp1; 6g), NusA
(8 g), NusA-CPL1 (12 g), and NusA-CPL2 (12 g) were analyzed by SDSPAGE. The polypeptides were visualized by staining with Coomassie blue dye. The
positions and sizes (in kDa) of marker proteins are indicated on the left. The polypeptides corresponding to the full-length NusA-CPL fusion proteins are indicated
by arrows. (B and C) CTD phosphatase activity. Reaction mixtures (25 l) containing 50 mM Tris-acetate (pH 5.5), 10 mM MgCl2, either 22 M CTD Ser-5-PO4
phosphopeptide (YSPTSPS)4 (containing 2.2 nmol of input Ser-PO4) or 25 M CTD Ser-2-PO4 phosphopeptide (YSPTSPS)4 (containing 2.5 nmol of input Ser-PO4),
and recombinant proteins as specified were incubated for 60 min at 37°C. Phosphate release is plotted as a function of input protein.
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Upon treatment with CPL11–638, GST-AtCTDO was no longer
recognized by H14, but it retained its immunoreactivity with H5.
The selective elimination of H14 reactivity by CPL1 was
magnesium-dependent and was evident when the reactions were
performed at its optimum acidic pH (pH 5.5) and neutral pH
(pH 7.0). Similar results were obtained for recombinant CPL2
(data not shown). The specificity of CPL1 and CPL2 for de-
phosphorylation of Ser-5 was underscored by the finding that
treatment with the generic phosphatase calf intestine alkaline
phosphatase abolished the reactivity of GST-AtCTDO to both
H14 and H5 antibodies and reverted the electrophoretic mobility
of GST-AtCTDO to that of unphosphorylated GST-AtCTDA
(Fig. 3).
CPL1 Localizes to the Arabidopsis Nucleus. The subcellular localiza-
tion of CPL1 and CPL2 was analyzed by transiently expressing
tandem affinity purification (TAP)-GFP-CPL fusion proteins in
Arabidopsis protoplasts (Fig. 4). The DsRed protein fused to the
simian virus 40 (SV40) large T antigen nuclear localization signal
(NLS) (31) was used as a positive control for nuclear targeting.
In protoplasts expressing TAP-GFP-CPL1, green fluorescence
was detected exclusively in nuclei and colocalized with red
fluorescence from NLSSV40-DsRed (Fig. 4A). The nuclear lo-
calization of CPL1 is consistent with genetic evidence that CPL1
regulates the transcription of stress-responsive genes. In proto-
plasts expressing TAP-GFP or TAP-GFP-CPL2, a diffuse pat-
tern of green fluorescence was observed in cytosol and nucleus,
indicating that neither protein had been targeted to a specific
subcellular compartment. To further dissect the signals for
nuclear targeting of CPL1, three polypeptide segments were
fused individually to the C terminus of GFP (with no N-terminal
TAP tag) to generate chimeric proteins GFP-CPL11–150, GFP-
CPL1151–639, and GFP-CPL1640–967. Only GFP-CPL1 640–967 was
specifically targeted to nuclei (Fig. 4G).
Localization of a discrete NLS within the CPL1640–967 was
achieved by fusing a series of CPL1 peptide fragments to GFP
(Fig. 8, which is published as supporting information on the
PNAS web site). The results show that (i) the dsRBM motifs play
no apparent role in nuclear targeting; (ii) a 23-aa C-terminal
peptide, CPL1945–967 sufficed for nuclear localization of GFP;
and (iii) deletion of amino acids 945–957 abolished the NLS
Fig. 2. Effects of N-terminal and C-terminal deletions on AtCPL1 CTD
phosphatase activity. (A) GST-CPL1 fusions. Aliquots of the affinity-purified
GST-AtCPL1 fusion proteins CPL11–638, CPL147–638, CPL11–563, and CPL11–500
containing 0.1 g of the respective GST-CPL1 fusion polypeptides were
analyzed by SDSPAGE. The Coomassie blue-stained gel is shown. The posi-
tions and sizes (kDa) of marker proteins are indicated on the left. The polypep-
tides corresponding to the GST-CPL1 fusions are indicated by arrows. (B) CTD
phosphatase activity. Reaction mixtures (25l) containing 50 mM Tris-acetate
(pH 5.5), 10 mM MgCl2, either 32 M CTD Ser-5-PO4 phosphopeptide
(YSPTSPS)4 (containing 3.2 nmol of input Ser-PO4) or 36 M CTD Ser-2-PO4
phosphopeptide (YSPTSPS)4 (containing 3.6 nmol of input Ser-PO4), and0.1
g of the GST-CPL1 fusion polypeptides as specified were incubated for 60 min
at 37°C. Representative results from three independent experiments are
shown.
Fig. 3. CPL1 dephosphorylates intact AtCTD. GST-AtCTD protein was phos-
phorylated by activated mitogen-activated protein kinase ERK2. After over-
night dialysis, GST-AtCTDO was incubated with 0.1 g (1) or 0.2 g (2) of
the GST-CPL11–638 preparation (CPL1) or calf intestine alkaline phosphatase
(CIAP) in reaction buffer (50 mM Tris, pH 5.5 or 7.0) without or with 10 mM
MgCl2 for 3 h at 37°C. Phosphorylation status was gauged after resolving the
products by SDSPAGE by immunoblotting with mAbs H14 and H5 that detect
Ser-5-PO4 and Ser-2-PO4, respectively. (Lower) The polypeptide compositions
were visualized by staining with Coomassie brilliant blue dye (CBB). The
amount of GST-AtCTD applied to the gels was 0.1 g for H14 and 1 g for H5
and CBB staining.
Fig. 4. Subcellular localization of CPL1 and CPL2. TAP-GFP-CPL1 (A), TAP-
GFP-CPL2 (B), TAP-GFP (C), GFP-CPL11–150 (E), GFP-CPL1 151– 639 (F), GFP-
CPL1640–967 (G), and GFP (H) were transiently expressed in Arabidopsis proto-
plasts. NLSSV40-DsRed was used as a positive control for nuclear localization (D)
and was coexpressed with GFP-fusion constructs (A–C and E–G). Fluorescent
signals from GFP and DsRed were obtained by using standard FITC and
rhodamine filter sets. The pictures show pseudocolor overlap images of GFP
(green) and DsRed (red). Yellow indicates colocalization of GFP and RFP fusion
proteins. (Scale bars: 10 m.)
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activity (Fig. 8A). The C-terminal NLS region of Arabidopsis
CPL1 is conserved in the rice CPL1 homolog (Fig. 8B).
CPL1 and CPL2 Have an Essential Redundant Function in Plant Devel-
opment. T-DNA insertion or splice-junction mutations in the
CPL1 gene altered ABA sensitivity and freezing sensitivity in
Arabidopsis seedlings, but did not cause lethality or a severe
growth defect (6). This finding is in contrast to the lethality of
fcp1 loss-of-function mutations in fungi (17). To test functional
redundancy between CPL1 and CPL2, we gauged the effect of
combining the cpl1fry2 mutation with the cpl2–2 allele, which
contains a T-DNA insertion in the ninth exon of CPL2 that
disrupts its expression (Fig. 7). The cpl2–2 mutation by itself
causes early flowering in homozygous mutant plants (similar to
the effects of the fry2–1 and cpl3–1 mutations) and reduced
fertility. Nonetheless, homozygous cpl2–2 plants were able to
complete their life cycle and produce viable seeds (unpublished
observations). When we analyzed the genotype of F2 progeny of
a fry2–1 cpl2–2 F1 plant, no homozygous fry2–1 cpl2–2
double mutants were identified in 76 seedlings. The segregation
ratio of each locus indicated the synthetic lethality of the fry2–1
cpl2–2 gamete rather than zygotes (data not shown). To deter-
mine the specific gametophytic lethality, the genotypes of F1
progeny from the reciprocal cross between fry2–1 and fry2–1
cpl2–2 were analyzed (Table 1). Individual F1 plants were first
scored for fry2–1 phenotype by using luciferase imaging analysis
to assay overexpression of an integrated luciferase reporter
driven by the RD29a promoter (indicative of homozygosity for
fry2–1) (5). The plants were then tested for the cpl2–2 T-DNA
insertion by PCR. When the fry2–1 plant was used as a pollen
donor, 12 of 23 fry2–1 F1 plants contained cpl2–2 T-DNA,
indicating that the fry2–1 and cpl2–2 mutations can be cotrans-
mitted through the megagametephyte. In contrast, no cpl2–2
T-DNA was detected in 36 fry2–1 F1 plants when the fry2–1
cpl2–2 plant was used as the pollen donor. These results
established that the fry2–1 and cpl2–2 mutations cannot cotrans-
mit through the pollen, and thus at least one functional CPL1
family gene is required for normal plant development.
Discussion
Here we report that Arabidopsis CPL1 and CPL2 catalyze the
metal-dependent hydrolysis of phosphoserine at position 5 of the
CTD repeat YSPTSPS, but are apparently incapable of remov-
ing phosphoserine at position 2. The N-terminal half of the plant
CPL1 protein that suffices for CTD Ser-5 phosphatase activity
includes the FCPH module found in all fungal and metazoan
CTD-specific phosphatases. Indeed, the plant CPL proteins are
notable for conservation of all 11 amino acid side chains that
were shown to be essential or important for the CTD phospha-
tase activity of S. pombe Fcp1 (see Fig. 5) (32). Thus, we predict
that the architecture of the active site of the plant CPL1 and
CPL2 enzymes is similar to that of other CTD phosphatases of
the DXDXT family. In this light, the most striking property of the
plant CPL1 and CPL2 phosphatases is their stringent inherent
selectivity for Ser-5 versus Ser-2, which can be observed both
with a synthetic peptide substrate and full-length AtCTD. This
finding contrasts most starkly with the behavior of S. pombe
Fcp1, which displays a 10-fold preference for dephosphorylating
Ser-2-PO4 versus Ser-5-PO4 when assayed with the same set of
tetraheptad CTD-PO4 substrate used here to characterize the
plant enzymes (21). On the other hand, E. cuniculi Fcp1 and the
human SCP dephosphorylate both Ser-5 and Ser-2, with a slight
(2-fold) preference for Ser-5. Human Fcp1 dephosphorylates
both Ser-5 and Ser-2 (26, 30).
Recently, Krishnamurthy et al. (33) reported a specific CTD
Ser-5 phosphatase activity associated with S. cerevisiae Ssu72,
which contains an cysteinyl-phosphatase-type active site and
bears no resemblance to the acyl-phosphatase family to which
the CPLs belong. Although Arabidopsis encodes a putative Ssu72
homolog, it has not been characterized genetically or biochem-
ically. The fact that the fry2–1 cpl2–2 double-mutation ablates
male gamete function suggests that the Ser-5-specific phospha-
tase activity of the CPL1 and CPL2 proteins does not overlap
functionally during plant development with a putative activity
contributed by plant Ssu72. Given that multiple CTD kinases
differentially phosphorylate the CTD at distinct phases of the
transcription cycle in metazoans and fungi, it is reasonable to
think that the CPLs and Ssu72 differentially dephosphorylate
Pol II in an analogous fashion.
Two other remarkable features of the plant CPLs emerge from
the present study. First, CPL1 and CPL2 have CTD phosphatase
activity, although they lack the essential BRCT domain found in
fungal, metazoan, and plant Fcp1 homologs. The catalytic
contributions made by the BRCT domain of Fcp1 are not known,
but a recent report implicates the BRCT domain in the initial
binding of Fcp1 to the phosphorylated CTD (34). The present
study underscores the insight from the recent discovery of
human SCPs, that not all CTD phosphatases rely on a BRCT
domain to achieve either CTD-PO4 recognition or positional
specificity for a particular Ser-PO4 within the CTD heptad.
Second, CPL1 and CPL2 are distinguished by the presence of
putative dsRBMs on the carboxyl side of the FCPH domain. The
simple notion that a dsRBM functions in lieu of the BRCT
domain to promote CTD recognition is vitiated by the finding
that deletion of the C-terminal segment containing both
dsRBMs did not eliminate CTD phosphatase activity or alter its
positional specificity. We conclude that the unique specificity of
the plant CPL1 and CPL2 proteins for Ser-5 is intrinsic to the
N-terminal catalytic domain. We show here that the CTD of
CPL1 plays an ancillary role in nuclear targeting. It is likely that
nuclear targeting is critical for CPL1 to function as a transcrip-
tional regulator in vivo, insofar as deletion of the NLS-containing
C-terminal peptide in the fry2–1 mutant plants results in a
hyperactive transcriptional response to stress. Of course, it is
possible that the CTD plays additional roles in vivo, e.g.,
promoting protein–protein or protein–RNA interactions that
direct the plant CTD phosphatase to specific genes or otherwise
regulate its activity. Indeed, we recently determined that the
Table 1. Reciprocal cross analysis indicated synthetic lethality in fry2–1 cpl2–2 male gamete
Cross
Total WT phenotype
fry2–1 phenotype,
genotype
Female Male CPL2 cpl2–2
fry2–1  fry2–1cpl2–2 112 76 36 0
fry2–1 cpl2–2  fry2–1 62 39 12 11
Each F1 seedling was first scored for fry2–1 phenotype by using RD29a-LUC expression after cold treatment (0°C,
48 h) and then after ABA treatment (100 M, 3 h). Seedlings with fry2–1 phenotype were recovered, and their
genomic DNA was extracted. The CPL2 genotype of fry2-1 F1 seedlings was determined by detecting T-DNA
insertion in CPL2 by using PCR.
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CTD of CPL1 can interact with dsRNA in vitro (A.H., R. Ito,
N.K., Y. Nomura, D. Aizawa, Y. Murai, H.K., M. Seki, K.
Shinozoki, and T.F., unpublished work). Precedent for RNA-
mediated control of the CTD phosphorylation state emerged
from the discovery that the activity of the mammalian CTD
kinase PTEF-b is negatively regulated by binding to 7SK RNA
(35–37).
The analysis of genetic interactions between the fry2–1cpl1
and cpl2–2 alleles indicated that either CPL1 or CPL2 is required
for male gamete function. Although the precise timing of the
developmental arrest or demise of the fry2–1 cpl2–2 double-
mutant pollen has not been determined, the fact that the fry2–1
cpl2–2 double mutation can transmit through female gametes
indicates that specific CTD phosphatase isozymes are required
in different types of cells. The dispensability of CPL1 and CPL2
in female gametes contrasts with the results obtained with
Xenopus oocytes, where FCP1 is required to covert the hyper-
phosphorylated, but transcriptionally quiescent, pool of Pol IIO
that is stored in the oocyte to hypophosphorylated Pol IIA,
so that it can be recruited to preinitiation complexes upon
fertilization (38).
Phosphorylation of CTD Ser-5 is believed to be a key step in
the transition from initiation to elongation by fungal and meta-
zoan Pol II and is also implicated in ensuring the timely capping
of nascent pre-mRNAs (39). If similar CTD phosphorylation
dynamics pertain in plants, then the action of CPL1 as a negative
regulator of the transcriptional response to stress could be
explained in several ways. CPL1 could decrease elongation
complex formation by stripping Ser-5-PO4 from the initiation
complex and thereby affecting promoter clearance. Alterna-
tively, dephosphorylation of Ser-5 in the early elongation com-
plex might negatively affect the efficiency or timing of cotrans-
criptional mRNA capping. The latter model is appealing in light
of the finding that a recessive mutation in the plant ABH1 gene
encoding a nuclear cap binding protein causes attenuation of
ABA induction of at least 18 Arabidopsis genes (4). In contrast,
the predominant molecular phenotype of ssu72 mutation is the
incomplete termination of small nucleolar RNA and some
mRNA transcription by Pol II (40).
The specificity of the CPL1CPL2 paralog pair for hydrolyzing
Ser-5-PO4 raises the prospect that the other plant paralog pair
CPL3CPL4 is responsible for removing Ser-2-PO4 from the
plant CTD. Unfortunately, our efforts to evaluate this idea by
purifying and characterizing Arabidopsis CPL3 or CPL4 were
thwarted by the inability to produce sufficient amounts of soluble
recombinant CPL3 or CPL4 proteins in bacteria. Based on the
present study of CPL1 and CPL2, we anticipate that further
genetic and biochemical dissection of the specificity, expression,
localization, and structure–function relationships of all four CPL
proteins will provide insights into the role of CTD phosphory-
lation dynamics in gene-specific transcriptional control during
development of a multicellular organism and in adaptation to
environmental stress.
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